Immucor (NASDAQ:BLUDE)
Historical Stock Chart
From Jun 2019 to Jun 2024
Lasky & Rifkind, Ltd., a law firm with offices in New
York and Chicago, announces that a lawsuit has been filed in the
United States District Court for the Northern District of Georgia, on
behalf of persons who purchased or otherwise acquired publicly traded
securities of Immucor, Inc. ("Immucor" or the "Company")
(NASDAQ:BLUDE) between January 7, 2005 and August 29, 2005, inclusive,
(the "Class Period"). The lawsuit was filed against Immucor, Dr.
Gioacchino De Chirico, Steven C. Ramsey and Edward L. Gallup
("Defendants").
If you are a member of this class and wish to view a copy of a
complaint and join this class action, please e-mail us at
investorrelations@laskyrifkind.com and request a copy of the complaint
and a plaintiff certification. If you are a member of the Class, you
may move the Court no later than October 31, 2005 to serve as a lead
plaintiff for the Class. Any member of the purported class may move
the Court to serve as lead plaintiff through counsel of their choice,
or may choose to do nothing and remain an absent class member.
However, if you choose to remain an absent class member, unless and
until a class is certified, you are not represented by counsel.
The complaint alleges that Defendants violated Sections 10(b) and
20(a) of the Securities Exchange Act of 1934 and Rule 10b-5
promulgated thereunder. Specifically, the complaint alleges that
Defendants misrepresented that the Company's financial statements and
disclosures fairly and accurately reflected the Company's results from
operations as required by Generally Accepted Accounting Principles
("GAAP").
On August 26, 2005, the Company was forced to announce that the
SEC had launched a formal investigation into payments made by its
Italian unit and its President, Mr. De Chirico, in October 2003 to a
physician connected with a hospital with which the Company was doing
business. Then, after the market closed on August 29, 2005, the
Company indicated in a press release that it would be revising its
previously issued results for at least two quarters in order to
account for previously unrecorded accrued bonuses. In reaction to the
news, Immucor's common stock price fell from $28.61 on August 25, 2005
to close at $24.00 on August 20, 2005.
If you bought Immucor securities between January 7, 2005 and
August 29, 2005, inclusive, and would like to obtain information about
the lawsuit, then you are invited to call (800) 495-1868 to speak with
an advisor.